Clinical trial
Epidemiology and Burden of Nocturia Due to Nocturnal Polyuria in the United States: The EpiNP Study
NCT04125186 is registered in ClinicalTrials.gov with Ferring Pharmaceuticals as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Epidemiology and Burden of Nocturia Due to Nocturnal Polyuria in the United States: The EpiNP Study
- Lead sponsor
- Ferring Pharmaceuticals
- Phase
- Observational
- Overall status
- Completed
- Start date
- July 22, 2019
- Completion date
- June 30, 2020
- Enrollment
- 10,190 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
nocturnal polyuria